Concepedia

Pazopanib in patients with von Hippel-Lindau disease: a single-arm, single-centre, phase 2 trial

Eric Jonasch, Ian E. McCutcheon, Dan S. Gombos, Kamran Ahrar, Nancy D. Perrier, Diane Liu, Christine Robichaux, Mercedes F Villarreal, Justin A. Weldon, Ashley Woodson,

The Lancet Oncology · 2018 · 101 citations · 23 references

DOIFull text

Open access

Concepts

References

23

The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis

Patrick H. Maxwell, Michael S. Wiesener, Gin-Wen Chang et al. · Nature · 1999 · 5.2K citations

, , +14

Identification of the von Hippel-Lindau Disease Tumor Suppressor Gene

Farida Latif, Kálmán Tory, James R. Gnarra et al. · Science · 1993 · 3K citations

, , +17

Pazopanib in Locally Advanced or Metastatic Renal Cell Carcinoma: Results of a Randomized Phase III Trial

Cora N. Sternberg, Ian D. Davis, Jozef Mardiak et al. · Journal of Clinical Oncology · 2010 · 2.5K citations · Full text

, , +17

Pazopanib versus Sunitinib in Metastatic Renal-Cell Carcinoma

Robert J. Motzer, Thomas E. Hutson, David Cella et al. · New England Journal of Medicine · 2013 · 1.9K citations · Full text

, , +13

Efficacy and Safety of Pazopanib in Patients With Metastatic Renal Cell Carcinoma

Thomas E. Hutson, Ian D. Davis, Jean‐Pascal Machiels et al. · Journal of Clinical Oncology · 2009 · 293 citations

, , +14